Boothwyn Pharmacy LLC: Drug Recall
Recall #D-0609-2025 · 07/09/2025
Class II: Risk
Recall Details
- Recall Number
- D-0609-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Boothwyn Pharmacy LLC
- Status
- Ongoing
- Date Initiated
- 07/09/2025
- Location
- Kennett Square, PA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 648 vials
Reason for Recall
Subpotent Drug
Product Description
Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy
Distribution Pattern
U.S. Nationwide
Other Recalls by Boothwyn Pharmacy LLC
- Class II: Risk 07/09/2025
- Class III: Low Risk 07/09/2025
- Class II: Risk 07/09/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.